Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Taking Another Shot At Public Market, Amicus Files $86M IPO

April 2, 2007

By Jennifer Boggs

Avanir Cutting Costs, Exploring Options To Fund Zenvia Work

March 30, 2007

By Jennifer Boggs

Avanir Cutting Costs, Exploring Options To Fund Zenvia Work

March 30, 2007

By Jennifer Boggs

MAP's Asthma, Migraine Drug Work Boosted By $50M Series D

March 29, 2007

By Jennifer Boggs

MAP's Asthma, Migraine Drug Work Boosted By $50M Series D

March 29, 2007

By Jennifer Boggs

Regeneron Rises On Interim VEGF Trap-Eye Data In AMD

March 28, 2007

By Jennifer Boggs

Regeneron Rises On Interim VEGF Trap-Eye Data In AMD

March 28, 2007

By Jennifer Boggs

Affinium Raises $18M In Series A; Lead Antibiotic Moving Into Clinic

March 27, 2007

By Jennifer Boggs

Affinium Raises $18M In Series A; Lead Antibiotic Moving Into Clinic

March 27, 2007

By Jennifer Boggs

NASA technology forms basis of stem cell firm Regenetech

March 26, 2007

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...